TP53 and cancer: As depicted in Fig. 3A, the most common concomitant genomic alterations involved TP53, EGFR and FAT1. Notably, LUAD was identified as the cancer type with the highest frequency of co-mutations, followed by COAD, BRCA, and NSCL (Fig. 3B).